Food and Drug Administration

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

August 19, 2026

Teva Pharmaceutical Industries Ltd Ecopipam (EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designation NDA…

MMedication

The FDA Issued a Recall on Bladder Medication Nationwide

August 14, 2026

Key Points A nationwide recall was issued for mirabegron tablets due to an impurity in the active ingredient.…

MMedication

FDA says recalled blood thinner sold across the US is unlikely to cause serious harm

August 11, 2026

A recalled generic blood thinner has drawn national attention. But the U.S. Food and Drug Administration says the…

MMedication

Blood Pressure Drug Recalled Nationwide, FDA Announces

August 11, 2026

When a prescription drug is recalled, often it’s a generic version that’s being pulled from market. But this…

MMedication

Medicare’s Drug-Pricing Proposal Carries A Hidden Cost

August 11, 2026

“CMS’s proposal would encourage one thing above all else: investing less in improving existing medicines,” says health expert…

MMental health

Major VA study to examine effectiveness of psilocybin on depression, PTSD

August 6, 2026

The Department of Veterans Affairs is launching research to determine whether psilocybin — the psychoactive ingredient in “magic…

MMedication

Antihistamine Recall: 34,000 Bottles at Highest Risk Level

August 6, 2026

It’s not the first recall we’ve seen for antihistamine, but it might be one of the first with…

MMedication

FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease

July 28, 2026

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Mannkind…

MMedication

What to Know About Peptides the FDA Is Considering for Use

July 25, 2026

An advisory committee to the Food and Drug Administration convened Thursday to evaluate whether compounding pharmacies should be…

MMedication

What to Know About the New Cholesterol Pill and How it Compares to Statins

July 25, 2026

Patients who need to lower their cholesterol will soon have a powerful new option. On Thursday, the Food…

MMedication

GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds

July 23, 2026

A Food and Drug Administration advisory panel will spend the next two days discussing whether compounding pharmacies can…

NNutrition

Popular Supplement Recalled Due to Salmonella Risk: Nausea and Bloody Diarrhea Possible

July 23, 2026

Your morning supplement could make you sick. The U.S. Food and Drug Administration (FDA) announced that Moringa Leaf…

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

The FDA Issued a Recall on Bladder Medication Nationwide

FDA says recalled blood thinner sold across the US is unlikely to cause serious harm

Blood Pressure Drug Recalled Nationwide, FDA Announces

Medicare’s Drug-Pricing Proposal Carries A Hidden Cost

Major VA study to examine effectiveness of psilocybin on depression, PTSD

Antihistamine Recall: 34,000 Bottles at Highest Risk Level

FDA Approves Mannkind’s At-Home Treatment Option for Heart Failure or Kidney Disease

What to Know About Peptides the FDA Is Considering for Use

What to Know About the New Cholesterol Pill and How it Compares to Statins

FDA panel reviewing some peptides to consider loosening regulations for unapproved therapies

Popular Supplement Recalled Due to Salmonella Risk: Nausea and Bloody Diarrhea Possible